Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

First response to a BET inhibitor seen in NUT midline carcinoma

Dec. 7, 2015

First-in-human data for ASTX-727 in myelodysplastic syndromes presented at ASH

Dec. 7, 2015

Multiple dosing begun in phase I trial of CCX-872-B in pancreatic cancer

Dec. 7, 2015

New inhibitors block Ewing's sarcoma cell growth in vitro and in vivo

Dec. 7, 2015

Fluorescent tracer MB-102 devised for noninvasive glomerular filtration rate measurement

Dec. 7, 2015

Coordinated delivery of anticancer drug combinations reduces toxicity

Dec. 7, 2015

Novel enolase inhibitor shows in vivo antineoplastic activity

Dec. 4, 2015

Phase I studies evaluate repurposed mibefradil with radiotherapy or chemotherapy in glioma patients

Dec. 4, 2015

Novel ADCs have a significant cytotoxic effect both in vitro and in vivo

Dec. 4, 2015

First-in-human results lead to phase II planning for ABTL-0812

Dec. 4, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...